Cargando…

Correction to: Ibalizumab: First Global Approval

Detalles Bibliográficos
Autor principal: Markham, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993838/
https://www.ncbi.nlm.nih.gov/pubmed/29846911
http://dx.doi.org/10.1007/s40265-018-0926-2
_version_ 1783330295104143360
author Markham, Anthony
author_facet Markham, Anthony
author_sort Markham, Anthony
collection PubMed
description
format Online
Article
Text
id pubmed-5993838
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-59938382018-06-21 Correction to: Ibalizumab: First Global Approval Markham, Anthony Drugs Correction Springer International Publishing 2018-05-30 2018 /pmc/articles/PMC5993838/ /pubmed/29846911 http://dx.doi.org/10.1007/s40265-018-0926-2 Text en © Springer Nature 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Markham, Anthony
Correction to: Ibalizumab: First Global Approval
title Correction to: Ibalizumab: First Global Approval
title_full Correction to: Ibalizumab: First Global Approval
title_fullStr Correction to: Ibalizumab: First Global Approval
title_full_unstemmed Correction to: Ibalizumab: First Global Approval
title_short Correction to: Ibalizumab: First Global Approval
title_sort correction to: ibalizumab: first global approval
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993838/
https://www.ncbi.nlm.nih.gov/pubmed/29846911
http://dx.doi.org/10.1007/s40265-018-0926-2
work_keys_str_mv AT markhamanthony correctiontoibalizumabfirstglobalapproval